Yapeng Su, Dan Yuan, Daniel G Chen, Rachel H Ng, Kai Wang, Jongchan Choi, Sarah Li, Sunga Hong, Rongyu Zhang, Jingyi Xie, Sergey A Kornilov, Kelsey Scherler, Ana Jimena Pavlovitch-Bedzyk, Shen Dong, Christopher Lausted, Inyoul Lee, Shannon Fallen, Chengzhen L Dai, Priyanka Baloni, Brett Smith, Venkata R Duvvuri, Kristin G Anderson, Jing Li, Fan Yang, Caroline J Duncombe, Denise J McCulloch, Clifford Rostomily, Pamela Troisch, Jing Zhou, Sean Mackay, Quinn DeGottardi, Damon H May, Ruth Taniguchi, Rachel M Gittelman, Mark Klinger, Thomas M Snyder, Ryan Roper, Gladys Wojciechowska, Kim Murray, Rick Edmark, Simon Evans, Lesley Jones, Yong Zhou, Lee Rowen, Rachel Liu, William Chour, Heather A Algren, William R Berrington, Julie A Wallick, Rebecca A Cochran, Mary E Micikas, Terri Wrin, Christos J Petropoulos, Hunter R Cole, Trevan D Fischer, Wei Wei, Dave S B Hoon, Nathan D Price, Naeha Subramanian, Joshua A Hill, Jennifer Hadlock, Andrew T Magis, Antoni Ribas, Lewis L Lanier, Scott D Boyd, Jeffrey A Bluestone, Helen Chu, Leroy Hood, Raphael Gottardo, Philip D Greenberg, Mark M Davis, Jason D Goldman, James R Heath
Post-acute sequelae of COVID-19 (PASC) represent an emerging global crisis. However, quantifiable risk factors for PASC and their biological associations are poorly resolved. We executed a deep multi-omic, longitudinal investigation of 309 COVID-19 patients from initial diagnosis to convalescence (2-3 months later), integrated with clinical data and patient-reported symptoms. We resolved four PASC-anticipating risk factors at the time of initial COVID-19 diagnosis: type 2 diabetes, SARS-CoV-2 RNAemia, Epstein-Barr virus viremia, and specific auto-antibodies...
March 3, 2022: Cell